Skip to main content
HRTX
NASDAQ Life Sciences

Heron Posts $35.3M Q3 Revenue, Down 7.8%, With No 2026 Outlook

Tom Rudovsky · Reported by Wiseek News
More coverage: Biotech Stocks · Healthcare
Sentiment info
Negative
Importance info
7
Price
$0.406
Mkt Cap
$55.627M
52W Low
$0.261
52W High
$1.575
52W Position info
55% above low
Off High info
74% below high
Rel. Volume info
0.5× avg
Market data snapshot near publication time

HRTX sits 55% above its 52-week low of $0.261.

Summary

Heron reported Q3 2026 net revenue of $35.3 million, down 7.8% year-over-year, and held $23.4 million in cash. The company is giving no financial guidance after withdrawing its full-year 2026 outlook in August. Commercial SUSTOL sales stopped September 30, 2026, removing a product from the revenue base without a quantified impact in the release. The results land the same morning Heron disclosed an agreement to sell substantially all of its assets to CorMedix for $145 million in cash plus 14,583,333 CorMedix shares, so the quarter's numbers matter mainly as a read on the business being handed over rather than as a standalone operating story.

At the time of this announcement, HRTX was trading at $0.41 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $55.6M. The 52-week trading range was $0.26 to $1.58. This news item was assessed with negative market sentiment and an importance score of 7 out of 10. Source: Wiseek News.


Price Chart

Share this article

Copied!

HRTX - Latest Insights

HRTX
Nov 09, 2026, 8:50 AM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $0.3924
Real-time Price: $0.3692 info
Change: -$0.0232 (-6%) info
Market Cap: $70.359M info
HRTX
Nov 09, 2026, 8:15 AM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $0.3792
Real-time Price: $0.3692 info
Change: -$0.010 (-3%) info
Market Cap: $70.359M info
HRTX
Nov 09, 2026, 7:40 AM EST
Filing Type: 8-K
Importance Score:
10
Price at Filing: $0.3841
Real-time Price: $0.3692 info
Change: -$0.0149 (-4%) info
Market Cap: $70.359M info
HRTX
Aug 17, 2026, 7:27 AM EDT
Source: Wiseek News
Importance Score:
7
Price at Filing: $0.3408
Real-time Price: $0.3692 info
Change: +$0.0284 (+8%) info
Market Cap: $70.359M info
HRTX
Aug 10, 2026, 8:00 AM EDT
Filing Type: 10-Q
Importance Score:
9
Price at Filing: $0.4307
Real-time Price: $0.3692 info
Change: -$0.0615 (-14%) info
Market Cap: $70.359M info